Business Context and Reporting Period
This Form 6-K/A filing by GlaxoSmithKline plc covers the period ending February 2015. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, in accordance with DTR 3.1.4 R(1)(a) and (c).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate governance disclosure and does not contain financial performance data.
Material Changes
The filing discloses a change in the shareholding interest of Mrs. V A Whyte, a Person Discharging Managerial Responsibility. On February 19, 2015, she transferred 6,927 Ordinary shares of GlaxoSmithKline plc to her husband, Mr. I Whyte, by way of gift.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total shareholding balance of Mrs. V A Whyte following the transfer of 6,927 shares.
- Confirm the reporting date of February 19, 2015, for the transaction notification.
- Note that this filing does not impact the company's financial statements or operational outlook.